Search
13/10/2023
Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib
Vallez-Valero L., Gasó-Gago I., Marcos-Fendian Á., Garrido-Alejos G., Riera-Magallón A., Plaza Diaz A., Martinez-Molina C., Mangues-Bafalluy M.A., Corominas H.. Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib. CLINICAL RHEUMATOLOGY. 2023; 42(12)DOI:10.1007/s10067-023-06787-2. PMID:37831336. IF:2.900(Q2/4D).
01/10/2023
Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group
Nezvalova-Henriksen K., Langebrake C., Bauters T., Moreno-Martinez M.-E., Ahnfelt E., Ekelund H., Domingos V., Pires V., Bonnin A., Bojanic I., Cabrerizo Y., Terwel S., Tam A.. Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group. BONE MARROW TRANSPLANTATION. 2023; 58(10)DOI:10.1038/s41409-023-02072-7. PMID:37528237. IF:4.500(Q1/2D).
01/10/2023
GEMA 5.3. Spanish Guideline on the Management of Asthma
Plaza Moral V., Alobid I., Álvarez Rodríguez C., Blanco Aparicio M., Ferreira J., García G., Gómez-Outes A., Garín Escrivá N., Gómez Ruiz F., Hidalgo Requena A., Korta Murua J., Molina París J., Pellegrini Belinchón F.J., Plaza Zamora J., Praena Crespo M., Quirce Gancedo S., Sanz Ortega J., Soto Campos J.G.. GEMA 5.3. Spanish Guideline on the Management of Asthma. Open Respiratory Archives. 2023; 5(4)DOI:10.1016/j.opresp.2023.100277. PMID:37886027. IF:(Q/D).
01/10/2023
The Interventions and Challenges of Antimicrobial Stewardship in the Emergency Department
Ruiz-Ramos, J, Escolà-Vergé, L, Monje-López, AE, Herrera-Mateo, S, Rivera, A. The Interventions and Challenges of Antimicrobial Stewardship in the Emergency Department. Antibiotics-Basel. 2023; 12(10)DOI:10.3390/antibiotics12101522. PMID:37887223. IF:4.300(Q1/2D).
01/07/2023
A critical view on the current use of daptomycin in Spain: The daptomise study
Gonzalez, CGR, de Vega, EC, Martinez, SD, Minero, MV, Urbon, JMG, Manzorro, AG, Martinez, EFD, Sacristan, SC, Santiago, EB, Alonso, AH, de Paredes, PMG, Saez, MS. A critical view on the current use of daptomycin in Spain: The daptomise study. Journal of Infection and Public Health. 2023; 16(7)DOI:10.1016/j.jiph.2023.05.008. PMID:37220712. IF:4.700(Q1/2D).
01/07/2023
PREDICTION OF MULTIDRUG-RESISTANT BACTERIA IN URINARY TRACT INFECTIONS IN THE EMERGENCY DEPARTMENT
Ruiz-Ramos, J, Monje-Lopez, AE, Medina-Catalan, D, Herrera-Mateo, S, Hernandez-Ontiveros, H, Rivera-Martinez, MA, Pereira-Batista, CS, Puig-Campmany, M. PREDICTION OF MULTIDRUG-RESISTANT BACTERIA IN URINARY TRACT INFECTIONS IN THE EMERGENCY DEPARTMENT. JOURNAL OF EMERGENCY MEDICINE. 2023; 65(1)DOI:10.1016/j.jemermed.2023.04.004. PMID:37385920. IF:1.200(Q3/7D).
01/06/2023
Medication assessment in older adults with cancer-Current practices in clinical pharmacy
Walsh, DJ, Kantilal, K, Herledan, C, Nightingale, G, Slavova-Boneva, V, Moreno-Martinez, ME, Penn, S, Chien, J, Kantilal, K. Medication assessment in older adults with cancer-Current practices in clinical pharmacy. Journal of Geriatric Oncology. 2023; 14(5)DOI:10.1016/j.jgo.2023.101531. PMID:37211515. IF:3.000(Q2/5D).
01/06/2023
Pharmaceutical care in the emergency department
Ramosa, JR, Hernanz, BC. Pharmaceutical care in the emergency department. Farmacia Hospitalaria. 2023; 47(3)DOI:10.1016/j.farma.2023.02.006. PMID:37088598. IF:(Q/D).